MetLife Investment Management’s Allegiance Bancshares ABTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,537
Closed -$439K 2884
2022
Q3
$439K Hold
10,537
﹤0.01% 1737
2022
Q2
$398K Hold
10,537
﹤0.01% 1824
2022
Q1
$471K Buy
10,537
+3,820
+57% +$167K ﹤0.01% 1807
2021
Q4
$284K Hold
6,717
﹤0.01% 1836
2021
Q3
$256K Sell
6,717
-2,377
-26% -$87.2K ﹤0.01% 1928
2021
Q2
$350K Hold
9,094
﹤0.01% 1794
2021
Q1
$369K Hold
9,094
﹤0.01% 1698
2020
Q4
$310K Hold
9,094
﹤0.01% 1749
2020
Q3
$213K Hold
9,094
﹤0.01% 1833
2020
Q2
$231K Hold
9,094
﹤0.01% 1816
2020
Q1
$219K Hold
9,094
﹤0.01% 1651
2019
Q4
$342K Hold
9,094
﹤0.01% 1662
2019
Q3
$292K Hold
9,094
﹤0.01% 1726
2019
Q2
$303K Buy
9,094
+3,269
+56% +$113K ﹤0.01% 1780
2019
Q1
$196K Hold
5,825
﹤0.01% 1994
2018
Q4
$189K Hold
5,825
﹤0.01% 1942
2018
Q3
$243K Hold
5,825
﹤0.01% 1971
2018
Q2
$253K Hold
5,825
﹤0.01% 1807
2018
Q1
$228K Hold
5,825
﹤0.01% 1815
2017
Q4
$219K Buy
+5,825
New +$225K ﹤0.01% 1876

Other funds holding ABTX

MetLife Investment Management's ABTX Position: Q4 2022 in Review

MetLife Investment Management sold out of Allegiance Bancshares (ABTX) in Q4 2022, closing a stake of 10,537 shares — an estimated $439K sold.

MetLife Investment Management first reported a position in ABTX in Q4 2017 and held it in 20 quarters. The position peaked at $471K in Q1 2022. 2 funds tracked by Wall St. Rank hold ABTX as of Q4 2022.

  • MetLife Investment Management reported no remaining Allegiance Bancshares position as of Q4 2022 after selling out during the quarter.
  • MetLife Investment Management sold 10,537 Allegiance Bancshares shares in Q4 2022, an estimated $439K.
  • MetLife Investment Management first reported a position in Allegiance Bancshares in Q4 2017 and held it in 20 quarters.
  • MetLife Investment Management's Allegiance Bancshares position peaked at $471K in Q1 2022.
  • 2 funds tracked by Wall St. Rank held Allegiance Bancshares as of Q4 2022.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.